ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

NCAB Committee Submits Drafts Of QRA Policy Statement

July 8, 1983

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Bill Would Require Medicare to Reimburse Costs of Trials

March 7, 1997